This inventor holds 14 USPTO granted patents and 11 published patent applications and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Genzyme Corporation, Sionna Therapeutics Inc., Eli Lilly and Company. Active years: 2008-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tewksbury, MA (US) (2008 - 2015)
- Andover, MA (US) (2016 - 2017)
Company Filing History:
13 out of 825 
2 out of 2 
1 out of 4,517 
Years Active: 2008-2026
Areas of Expertise:
Title: Innovations of Junkai Liao in Pharmaceutical Development
Introduction
Junkai Liao is a notable inventor based in Tewksbury, MA, who has made significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, Liao's work focuses on developing compounds that address critical health issues, particularly in the treatment of polycystic kidney disease and other related conditions.
Latest Patents
Liao's latest patents include innovative compounds known as 2-acylaminopropoanol-type glucosylceramide synthase inhibitors. These compounds are designed for use in treating polycystic kidney disease. The patents detail a pharmaceutical composition that comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. Furthermore, the methods outlined in these patents involve administering a therapeutically effective amount of the compound to subjects in need, thereby providing a potential treatment for various conditions, including type 2 diabetes and renal hypertrophy associated with diabetic nephropathy.
Career Highlights
Throughout his career, Junkai Liao has worked with prominent companies in the pharmaceutical industry, including Genzyme Corporation and Eli Lilly and Company. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Liao has collaborated with several professionals in the field, including Craig S. Siegel and Cecilia M. Bastos. These collaborations have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.
Conclusion
Junkai Liao's contributions to pharmaceutical innovation, particularly in the treatment of polycystic kidney disease, highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile